Datapoint: Centene Completes PANTHERx Sale

July 20

Centene Corp. last week completed its sale of specialty pharmacy arm PANTHERx to Vistria Group, General Atlantic and Nautic Partners. Centene originally purchased the rare drug company in December 2020. The insurer said in a July 14 press release that it intends to use the windfall to “repurchase stock and the balance to reduce debt.” Centene is also in the process of selling Magellan Rx to Prime Therapeutics, with the two deals valued at $2.8 billion. Centene is currently the fourth-largest insurer in the U.S., with 20,988,628 members.

Source: AIS’s Directory of Health Plans